Issued Patents All Time
Showing 1–25 of 26 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12350267 | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases | Michael Grey, Niall O'Donnell | 2025-07-08 |
| 12145959 | Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease | Michael Grey, Niall O'Donnell | 2024-11-19 |
| 11376251 | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases | Michael Grey, Niall O'Donnell | 2022-07-05 |
| 11260053 | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions | Andrew A. Young, Howard E. Greene | 2022-03-01 |
| 11229661 | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases | Michael Grey, Niall O'Donnell | 2022-01-25 |
| 10555950 | Bile acid recycling inhibitors for treatment of obesity and diabetes | Andrew A. Young, Howard E. Greene | 2020-02-11 |
| 10512657 | Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases | Michael Grey, Niall O'Donnell | 2019-12-24 |
| 10251880 | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions | Andrew A. Young, Howard E. Greene | 2019-04-09 |
| 10188646 | Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions | Andrew A. Young, Howard E. Greene | 2019-01-29 |
| 10028952 | Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereof | Andrew A. Young, Howard E. Greene | 2018-07-24 |
| 9345715 | Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereof | Andrew A. Young, Howard E. Greene | 2016-05-24 |
| 9339480 | Bile acid recycling inhibitors for treatment of obesity and diabetes | Andrew A. Young, Howard E. Greene | 2016-05-17 |
| 8481490 | Method of reducing plasma amylase and/or plasma lipase in patients with pancreatitis | Krystyna Tatarkiewicz, David G. Parkes, Denis-Claude Roy | 2013-07-09 |
| 8318663 | Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing agent | Andrew A. Young, Howard E. Greene | 2012-11-27 |
| 8288338 | Exendin and exendin agonists for eating disorders | Andrew A. Young, Sunil Bhavsar | 2012-10-16 |
| 8263554 | Methods of using GLP-1 receptor agonists to treat pancreatitis | Krystyna Tatarkiewicz, David G. Parkes, Denis-Claude Roy | 2012-09-11 |
| 8168233 | Treatment of pancreatitis with amylin | Andrew A. Young | 2012-05-01 |
| 8026210 | Exendins and exendin agonist analogs to regulate gastrointestinal motility | Andrew A. Young | 2011-09-27 |
| 7741269 | Exendins and exendin agonists for weight reduction and obesity | Andrew A. Young, Sunil Bhavsar | 2010-06-22 |
| 7521423 | Exendin pharmaceutical compositions | Andrew A. Young | 2009-04-21 |
| 7407932 | Methods for glucagon suppression using modified exendins | Andrew A. Young | 2008-08-05 |
| 7297761 | Pharmaceutical compositions containing exendins | Nigel Robert Arnold Beeley, Kathryn S. Prickett, Sunil Bhavsar, Andrew A. Young | 2007-11-20 |
| 7153825 | Methods for glucagon suppression using modified exendins | Andrew A. Young | 2006-12-26 |
| 7101853 | Method for treating or preventing gastritis using amylin or amylin agonists | Andrew A. Young, Gareth Wyn Beynon | 2006-09-05 |
| 6872700 | Methods for glucagon suppression | Andrew A. Young | 2005-03-29 |